Related Experiment Video
Updated: Apr 23, 2026
05:50
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
2.1K
Similarity-based modeling applied to signal detection in pharmacovigilance
S Vilar1, P B Ryan2, D Madigan3
11] Department of Biomedical Informatics, Columbia University, New York, New York, USA [2] Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.
CPT: Pharmacometrics & Systems Pharmacology
|September 25, 2014
Summary
This study enhances adverse drug event (ADE) detection by using similarity modeling on healthcare data. Prioritizing drug signals improves the efficiency of identifying potential safety concerns.
Area of Science:
- Pharmacovigilance and Drug Safety
- Computational Pharmacology
- Health Informatics
Background:
- Pharmacovigilance aims to detect adverse drug events (ADEs) using healthcare databases like electronic health records.
- Enhancing signal detection efficiency is crucial for timely assessment and follow-up of potential drug safety issues.
Purpose of the Study:
- To improve the precision of adverse drug event signal detection.
- To apply similarity-based modeling to prioritize candidate ADE associations identified through a medication-wide association study.
Main Methods:
- Utilized 2D and 3D molecular structure, ADE, target, and Anatomical Therapeutic Chemical (ATC) similarity measures.
- Applied similarity scoring to rank candidate ADE associations from a prior medication-wide association study.
- Focused on four specific ADE outcomes.
Main Results:
- Similarity-based modeling significantly improved the precision of ADE candidate ranking.
- The method effectively strengthened and prioritized signals derived from healthcare databases.
- Facilitated ADE detection by identifying similar drugs with available safety information.
Conclusions:
- Similarity modeling is a simple yet effective technique for enhancing pharmacovigilance signal detection.
- This approach aids in prioritizing potential adverse drug events for further investigation.
- Improves the overall efficiency of identifying drug safety signals from large-scale healthcare data.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
482
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
482
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
720
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
720
01:12Analysis of Population Pharmacokinetic Data
980
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
980
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
01:27Pharmacodynamic Models: Overview
150
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
150